• English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
Hong Kong-listed Kinsun Technology (09877.HK) surged over 4% in the afternoon after the company announced at midday that it expects its interim revenue to increase by 385% to 400% year-on-year.JPMorgan Chase: Raises its year-end 2026 target for the S&P 500 to 8,000 points, up from 7,800 points previously.On August 10th, Kinsys Technology (09877.HK) announced that the Group expects to achieve revenue of approximately RMB 63 million to RMB 65 million for the six months ended June 30, 2026, representing an increase of 385% to 400% year-on-year. Other income and gains are expected to be approximately RMB 9 million to RMB 11 million, totaling approximately RMB 72 million to RMB 76 million, representing an increase of RMB 47 million to RMB 51 million compared to the same period last year, representing an increase of 188% to 204% year-on-year. The main reasons for the performance growth during the reporting period include: 1. The Groups Ken-Valve transcatheter aortic valve system continued to achieve steady revenue growth. Ken-Valve is suitable for aortic regurgitation or stenosis, and its product design features and operational advantages have enabled the procedure to be rapidly promoted and applied in multi-level medical institutions; 2. The Group actively carried out paid clinical implantation of multiple structural heart disease interventional products overseas. The product’s excellent clinical efficacy and application advantages have been highly praised by key opinion leaders and experts around the world, and can meet the huge unmet clinical needs of structural heart disease worldwide.U.S. senior defense official Colby: The United States has more interests in the Indo-Pacific region than ever before, which means that investment in the region is stronger and growing.ADNOC Gas Division: Increased oil production in the UAE has boosted supply confidence.

Phillips 66 Trademarks Mark Lashier will Succeed Greg Garland as CEO

Haiden Holmes

Apr 13, 2022 09:44

P2.png


Lashier, a chemical engineer who joined the firm three decades ago in the chemicals division, was named president and chief operating officer a year ago after leading Chevron Phillips Chemical Co, the company's joint venture with Chevron Corp (NYSE:CVX), since 2017.


Garland has considered refining as a mature company and has concentrated its efforts on expanding its energy infrastructure, chemicals, and establishing a presence in electric vehicle battery components. It spent around $150 million last year for a 16.5% share in Novonix Ltd, an Australian provider of lithium-ion battery materials.


Garland "built a market-leading diversified energy manufacturing and logistics organization while investing for the future and producing solid financial returns," according to Glen Tilton, lead independent director of Philips 66.


Although the Houston company's non-refining initiatives have generated great shareholder returns, its shares have lately underperformed bigger competitors that benefitted from increasing gasoline margins during pandemic lockdowns.


Lashier is expected to pursue Garland's diversification approach, which includes biofuels, hydrogen, and battery components. However, he must demonstrate that he can match competitors Marathon Petroleum Corp (NYSE:MPC) and Valero Energy (NYSE:VLO), which increased shareholder returns by selling off retail operations and diversifying into renewable diesel, analysts said.


Phillips 66 (NYSE:PSX) traded at $81.97 on Tuesday, up 13% year to date, compared to 34% year-to-year gains at Marathon and Valero and around 96% year-to-date gains at PBF Energy (NYSE:PBF).


"Lashier's task is to increase the company's value," Matthew Blair, an analyst at Tudor Pickering Holt & Co., said. "He will face inquiries regarding the company's non-refining businesses' value and what he can do to boost stock price performance and capitalize on the potential valuation."